Serveur d'exploration H2N2

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Le cluster Immune response - Neutralization Tests

Terms

2Immune response
4Neutralization Tests
3Antibodies, Neutralizing (blood)
6Influenza Vaccines (immunology)
7Antibodies, Viral (blood)
6Hemagglutination Inhibition Tests
10Influenza A Virus, H2N2 Subtype (immunology)
2Vaccines, Inactivated (immunology)

Associations

Freq.WeightAssociation
20.707Immune response - Neutralization Tests
30.707Antibodies, Neutralizing (blood) - Influenza Vaccines (immunology)
30.655Antibodies, Neutralizing (blood) - Antibodies, Viral (blood)
40.617Antibodies, Viral (blood) - Hemagglutination Inhibition Tests
30.612Hemagglutination Inhibition Tests - Neutralization Tests
50.598Antibodies, Viral (blood) - Influenza A Virus, H2N2 Subtype (immunology)
20.577Influenza Vaccines (immunology) - Vaccines, Inactivated (immunology)
30.567Antibodies, Viral (blood) - Neutralization Tests
30.463Antibodies, Viral (blood) - Influenza Vaccines (immunology)
20.447Immune response - Influenza A Virus, H2N2 Subtype (immunology)
30.387Influenza A Virus, H2N2 Subtype (immunology) - Influenza Vaccines (immunology)
20.316Influenza A Virus, H2N2 Subtype (immunology) - Neutralization Tests

Documents par ordre de pertinence
000036 (2014) Gerald Aichinger [Autriche] ; Barbara Grohmann-Izay [Autriche] ; Maikel V. W. Van Der Velden [Autriche] ; Sandor Fritsch [Autriche] ; Manuela Koska [Autriche] ; Daniel Portsmouth [Autriche] ; Mary Kate Hart [États-Unis] ; Wael El-Amin [États-Unis] ; Otfried Kistner [Autriche] ; P. Noel Barrett [Autriche]Phase I/II Randomized Double-Blind Study of the Safety and Immunogenicity of a Nonadjuvanted Vero Cell Culture-Derived Whole-Virus H9N2 Influenza Vaccine in Healthy Adults
000062 (2011) Danuta M. Skowronski [Canada] ; Travis S. Hottes [Canada] ; Janet E. Mcelhaney [Canada] ; Naveed Z. Janjua [Canada] ; Suzana Sabaiduc [Canada] ; Tracy Chan [Canada] ; Beth Gentleman [Canada] ; Dale Purych [Canada] ; Jennifer Gardy [Canada] ; David M. Patrick [Canada] ; Robert C. Brunham [Canada] ; Gaston De Serres [Canada] ; Martin Petric [Canada]Immuno-epidemiologic Correlates of Pandemic H1N1 Surveillance Observations: Higher Antibody and Lower Cell-Mediated Immune Responses with Advanced Age
000074 (2010) Grace L. Chen [États-Unis] ; Elaine W. Lamirande [États-Unis] ; Chin-Fen Yang [États-Unis] ; HONG JIN [États-Unis] ; George Kemble [États-Unis] ; Kanta Subbarao [États-Unis]Evaluation of Replication and Cross-Reactive Antibody Responses of H2 Subtype Influenza Viruses in Mice and Ferrets
000041 (2014) Grace L. Chen [États-Unis] ; Elaine W. Lamirande [États-Unis] ; Xing Cheng [États-Unis] ; Fernando Torres-Velez [États-Unis] ; Marlene Orandle [États-Unis] ; Hong Jin [États-Unis] ; George Kemble [États-Unis] ; Kanta Subbarao [États-Unis]Evaluation of Three Live Attenuated H2 Pandemic Influenza Vaccine Candidates in Mice and Ferrets
000043 (2014) Irina Isakova-Sivak [Russie] ; J Rgen De Jonge [Pays-Bas] ; Tatiana Smolonogina [Russie] ; Andrey Rekstin [Russie] ; Geert Van Amerongen [Pays-Bas] ; Harry Van Dijken [Pays-Bas] ; Justin Mouthaan [Pays-Bas] ; Paul Roholl [Pays-Bas] ; Victoria Kuznetsova [Russie] ; Elena Doroshenko [Russie] ; Vadim Tsvetnitsky [États-Unis] ; Larisa Rudenko [Russie]Development and Pre-Clinical Evaluation of Two LAIV Strains against Potentially Pandemic H2N2 Influenza Virus
000018 (2017) Mizuho Suzuki ; Masatoshi Okamatsu ; Takahiro Hiono ; Keita Matsuno ; Yoshihiro SakodaPotency of an inactivated influenza vaccine prepared from A/duck/Hokkaido/162/2013 (H2N1) against a challenge with A/swine/Missouri/2124514/2006 (H2N3) in mice
000032 (2015) Irina Isakova-Sivak [Russie] ; Marina Stukova [Russie] ; Mariana Erofeeva [Russie] ; Anatoly Naykhin [Russie] ; Svetlana Donina [Russie] ; Galina Petukhova [Russie] ; Victoria Kuznetsova [Russie] ; Irina Kiseleva [Russie] ; Tatiana Smolonogina [Russie] ; Irina Dubrovina [Russie] ; Maria Pisareva [Russie] ; Alexandra Nikiforova [Russie] ; Maureen Power [États-Unis] ; Jorge Flores [États-Unis] ; Larisa Rudenko [Russie]H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers
000044 (2014) Mai-Juan Ma [République populaire de Chine] ; Xiao-Xian Yang [République populaire de Chine] ; Yan-Hua Qian [République populaire de Chine] ; Si-Yan Zhao [République populaire de Chine] ; Sha Hua [République populaire de Chine] ; Tie-Cheng Wang [République populaire de Chine] ; Shan-Hui Chen [République populaire de Chine] ; Guang-Yuan Ma [République populaire de Chine] ; Xiao-Yu Sang [République populaire de Chine] ; Lin-Na Liu [République populaire de Chine] ; Ai-Ping Wu [République populaire de Chine] ; Tai-Jiao Jiang [République populaire de Chine] ; Yu-Wei Gao [République populaire de Chine] ; Gregory C. Gray [États-Unis] ; Teng Zhao [République populaire de Chine] ; Xia Ling [République populaire de Chine] ; Jing-Lin Wang [République populaire de Chine] ; Bing Lu [République populaire de Chine] ; Jun Qian [République populaire de Chine] ; Wu-Chun Cao [République populaire de Chine]Characterization of a Novel Reassortant Influenza A Virus (H2N2) from a Domestic Duck in Eastern China
000128 (2002) Jason R. Williams [États-Unis] ; Po-Yen Chen ; Cheng T. Cho ; Tom D Y. ChinInfluenza: prospect for prevention and control.
000152 (1998) A. Natali [Italie] ; E. Pilotti [Italie] ; P. O. Valcavi [Italie] ; C. Chezzi [Italie] ; J. S. Oxford [Royaume-Uni]Natural and ‘ In vitro ’ selected antigenic variants of influenza A virus (H2N2)
000003 (2019) Z Beau Reneer [États-Unis] ; Ted M. Ross [États-Unis]H2 influenza viruses: designing vaccines against future H2 pandemics.
000009 (2018) Tara M. Babu [États-Unis] ; Ranawaka A P M. Perera ; Joseph T. Wu ; Theresa Fitzgerald [États-Unis] ; Carolyn Nolan [États-Unis] ; Benjamin J. Cowling ; Scott Krauss [États-Unis] ; John J. Treanor [États-Unis] ; Malik PeirisPopulation Serologic Immunity to Human and Avian H2N2 Viruses in the United States and Hong Kong for Pandemic Risk Assessment
000056 (2012) Jens C. Krause [États-Unis] ; Tshidi Tsibane [États-Unis] ; Terrence M. Tumpey [États-Unis] ; Chelsey J. Huffman [États-Unis] ; Randy Albrecht [États-Unis] ; David L. Blum [États-Unis] ; Irene Ramos [États-Unis] ; Ana Fernandez-Sesma [États-Unis] ; Kathryn M. Edwards [États-Unis] ; Adolfo Garcia-Sastre [États-Unis] ; Christopher F. Basler [États-Unis] ; James E. Jr Crowe [États-Unis]Human Monoclonal Antibodies to Pandemic 1957 H2N2 and Pandemic 1968 H3N2 Influenza Viruses
000061 (2011) Nicola Clementi [Italie] ; Donata De Marco ; Nicasio Mancini ; Laura Solforosi ; Guisella J. Moreno ; Larisa V. Gubareva ; Vasiliy Mishin ; Andrea Di Pietro ; Elisa Vicenzi ; Antonio G. Siccardi ; Massimo Clementi ; Roberto BurioniA human monoclonal antibody with neutralizing activity against highly divergent influenza subtypes.
000078 (2009) Rui Xu ; Ryan Mcbride ; James C. Paulson ; Christopher F. Basler ; Ian A. WilsonStructure, Receptor Binding, and Antigenicity of Influenza Virus Hemagglutinins from the 1957 H2N2 Pandemic▿ †
000169 (1987) N. Masurel [Pays-Bas]Influenza A and B antibody status in Tanzania
000221 (????) Z. Nikolova ; L Ia Zakstel'Skaia ; R. Kotseva ; E V Molibog[Age profile of the antihemagglutinins and antineuraminidase antibodies in type A influenza (author's transl)].

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021